GLP-1 Weight Maintenance Study
If you would like to learn more or are interested in participating, please email us at niche@tufts.edu or complete the eligibility screener under the description.
Have you recently stopped taking a GLP-1 medication, but worry about weight regain?
You may be eligible to participate in this study to see if there are ways to help people maintain weight loss after stopping a GLP-1. This study aims to test whether two alternative strategies, medically tailored meals and/or digital behavioral strategies, such as the Noom® app can help patients maintain weight loss and protect against weight regain for those who have to or want to stop taking GLP-1 RA's.
Who is eligible? Adult 18+, greater than 10% weight loss from taking GLP-1 RA medications (e.g., Trulicity, Bydureon bcise, Byetta, Ozempic, Victoza,Saxenda, Adlyxin, Rybelsus, etc.), less than 30 days since stopping medication.
What does it entail? Random assignment to one of three groups that receive usual care, a Noom® subscription, or medically tailored meals. Month 1: Remote weigh-in and questionnaire completed by phone or online, Month 2 & 3: Remote weigh-in, Month 4: Remote weigh-in & second questionnaire. Participants are paid up to $40 & receive a free bluetooth scale.
How do I sign up? Email, call, or text us if you'd like to participate or complete the eligibility screener by clicking here: https://redcap.link/5r9nwqej
Collaborators: Ildiko Lingvay, MD, MPH, MSCS
